Table 1: Fixed-Dose Combination ARVs by Generic Manufacturers

  • AZT/3TC: adult formulations by Aspen, Aurobindo, Cipla, Emcure, Hetero, Matrix, Ranbaxy and Strides. The Clinton Foundation has negotiated reduced prices with Cipla and Matrix. Paediatric formulation by Matrix.
  • AZT/3TC/ABC: adult formulations by Aurobindo (co-pack), Cipla, Hetero, Matrix, and Ranbaxy. No paediatric formulations.
  • AZT/3TC/NVP: adult formulations by Aspen (co-pack), Apotex, Aurobindo, Cipla, Hetero, Matrix, Emcure, Ranbaxy. The Clinton Foundation has negotiated reduced prices with Aurobindo, Hetero, Cipla and Matrix. Paediatric formulations by Matrix, Government Pharmaceutical Organization (GPO) and Ranbaxy. Not available from originator companies.
  • D4T/3TC/NVP: the Clinton Foundation has negotiated with Aurobindo, Hetero, Matrix, Cipla and Ranbaxy reduced prices for adult formulations. Adult formulation also made by Emcure and Strides. Paediatric formulations by Cipla, Hetero, GPO, Emcure, and Ranbaxy (reduced prices in Clinton’s consortium for versions by Cipla and Ranbaxy). Not available from originator companies.
  • ABC/3TC: adult formulation by Cipla. Paediatric formulations by Matrix and Aurobindo (reduced prices in Clinton’s consortium).
  • D4T/3TC: adult formulations by Aurobindo, Cipla, Hetero, Matrix, Ranbaxy, Emcure, and Strides. Paediatric formulations by Cipla, Emcure and Ranbaxy. Not available from originator companies. Reduced prices in Clinton’s consortium for versions by Aurobindo, Cipla, Hetero, Matrix, Ranbaxy, Strides.
  • Heat stable LPV/RTV: adult formulations by Aurobindo, Emcure, Cipla and Matrix (reduced price for Aurobindo, Cipla and Matrix versions in the Clinton Foundation’s consortium). Paediatric formulations by Aurobindo and Matrix. N.B.: generic soft gel capsule LPV/RTV are currently produced by Cipla and Hetero (no paediatric formulations).
  • D4T/3TC+EFV: adult formulations by Cipla, Emcure, Strides and Ranbaxy. No paediatric formulations. Not available from originator companies.
  • AZT/3TC+EFV: adult formulations by Aurobindo, Cipla, Emcure, Ranbaxy. No paediatric formulations. Not available from originator companies.
  • PMTCT: NVP+AZT: granule formulations by Strides. Not available from originator companies.
  • TDF/FTC: adult formulations by Cipla, Emcure, Hetero and Matrix (reduced price for Matrix version in the Clinton Foundation’s consortium). Not for paediatric use.
  • TDF/3TC: adult formulation by Matrix and Cipla (reduced price in the Clinton Foundation’s consortium). Not for paediatric use. Not available from originator companies.
  • TDF/FTC/EFV: adult formulation by Matrix (reduced price in the Clinton Foundation’s consortium), Emcure and Cipla. Not for paediatric use.
  • TDF/3TC+EFV: adult formulation by Cipla. Not for paediatric use. Not available from originator companies.
  • TDF/3TC/EFV: adult formulation by Matrix (reduced price in the Clinton Foundation’s consortium). Not for paediatric use. Not available from originator companies.
  • TDF/3TC+ATV+heat stable RTV (starting in 2010): by Mylan/Matrix (reduced price in the Clinton Foundation’s consortium). Not available from originator companies.

AZT = zidovudine, 3TC = lamivudine, ABC = abacavir, NVP = nevirapine, D4T = stavudine, LPV/RTV=lopinavir/ritonavir, EFV=efavirenz, TDF=tenofovir, FTC=emtricitabine, ATV = atazanavir, PMTCT = prevention mother-to-child transmission.WHO prequalified ARVs (updated list) at [53].Information mainly obtained from [15, 22].